Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial
Michael Brunini, Jean-Marie Forel, Xavier Muracciole, Antoine Roch, Dominique Barbolosi, Laurent Papazian
Topics & Concepts
MedicineNeuromuscular Blocking AgentsARDSPost-hoc analysisPain medicineAnesthesiologyBlocking (statistics)Post hocClinical trialIntensive care medicineAnesthesiaPhysical medicine and rehabilitationPhysical therapyInternal medicineLungStatisticsMathematicsRespiratory Support and MechanismsIntensive Care Unit Cognitive DisordersAnesthesia and Sedative Agents